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ABSTRACT
Objective: The purpose of this study is to evaluate the antidiabetic influence of Haematococcus pluvialis ethanol extract on streptozotocin-induced 
rats.
Methods: This influence was assessed by measuring asymmetric dimethylarginine (ADMA), von Willebrand factor (vWf), 15-lipoxygenase (15-LOX), 
5-LOX, epidermal growth factor (EGF), and lipoxin-A4 (LXA4). The histopathological examinations of cardiac and renal tissues were also performed.
Results: The presented results showed an elevation in the levels of ADMA, vWf, 15-LOX, and 5-LOX with percentages increase 430.30, 77.54, 61.05, 
and 81.09%, respectively in diabetic rats. However, the EGF and LXA4 levels were decreased significantly (44.17 and 51.94%, respectively), compared 
to normal control rats. On the other hand, treatment of diabetic rats with H. pluvialis improved ADMA, vWf, 15-LOX, 5-LOX, EGF, and LXA4 levels with 
amelioration percentages; 269.69, 54.77, 55.78, 72.68, 53.39, and 56.58%, respectively. In addition, the histopathological examination of cardiac tissue 
in diabetic rats revealed congestion of myocardial blood vessel, vacuolation of the sarcoplasm of cardiac myocytes and focal necrosis of myocytes 
associated with inflammatory cells infiltration. Beside, vacuolation of the epithelial lining of renal tubules and endothelial lining glomerular tuft 
as well as cystic dilatation of renal tubules was detected. However, cardiac tissue and renal tubules of diabetic rats treated with H. pluvialis ethanol 
extract (150 mg/kg b.wt.) showed normal cardiac myocytes, vacuolation of epithelial lining renal tubules and endothelial lining glomerular tuft, 
congestion of glomerular tuft and intertubular renal blood vessels.
Conclusion: These results confirmed the improving role of H. pluvialis in controlling type 2 diabetes.
Keywords: Haematococcus pluvialis, Streptozotocin, Type 2 diabetes, Asymmetric dimethylarginine, Von Willebrand factor, Lipoxygenases, 
Histopathological examination.
INTRODUCTION
Diabetes mellitus (DM) is a group of metabolic disorders of the endocrine 
system mainly divided into two types; type 1 DM (T1DM) and type 2 DM 
(T2DM) which characterized with hyperglycemia (high blood glucose 
level). T2DM represents the majority of diabetes conditions over the world, 
therefore; it is needed to find an economically and therapeutically effective 
treatment for usage in developing and under-developed countries [1]. 
The elevated levels of asymmetric dimethylarginine (ADMA) inhibit NO 
synthesis and therefore impair endothelial function and thus promote 
atherosclerosis and cardiovascular disorder [2] as well as in type 2 
diabetic patients with retinopathy [3]. Furthermore, ADMA is linked to the 
development of renal disease where, elevated levels of ADMA have been 
described [3], due to, ADMA is directly related to blood glucose levels [4].
With respect to epidermal growth factor (EGF), it is considered as an 
important biomarker in the restoration, mechanism, expressible on 
fibroblasts, epithelial cells, and promotes recovery of the damaged 
epithelium. In diabetic mice, these repaired cells can ameliorate flow 
of blood by elevating the rate of consistence of novel vessel, which also 
helps in the healing process [5]. It maintains the process of healing of 
oral and gastroesophageal ulcers through stimulation of DNA synthesis, 
cell migration and proliferation [6]. Moreover, EGF regulates the major 
function of the pancreas insulin secretion; it stimulates the secretion of 
insulin in a pancreatic beta-cell of mice [6]. In addition, EGF elevated 
the level of insulin so intercede the lowering of glucose in plasma of 
normal mice and diabetic one [6]. Hence, EGF is a new product that 
adjusts the levels of glucose in plasma and it regards as a choice for a 
therapeutic progress of diabetes [5].
Dynamically, the inflammatory process is a controlled procedures 
ranged by interfaces which perform critical adjusting function such 
as cytokines, chemokines, and lipid mediators; the lipoxins (LXs), 
resolvins, and protectins [7]. Moreover, human lipoxygenases (LOX) 
and their metabolites have been involved in several diseases including 
allergic rhinitis, cancer, asthma, allergy atherosclerosis, and diabetes [8]. 
Regarding to von Willebrand factor (vWf), it is endothelial cells 
synthesizing glycoprotein, implicated in adhesion and accumulation 
of platelet besides it is coagulation factor VIII carrier in plasma [9]. 
Further, the elevated vWF levels were connected with cardiovascular 
disease (CVD) risk in patients with T2DM or resistance of insulin, 
proposing that vWF is a critical marker unique to these disorders [9].
The rapiers used in diabetes have limited efficacy or side effects such 
as hypoglycemia, body weight gain, flatulence, and gastrointestinal 
disorders [10]. Unusual marine environments are attributed to different 
bioactive compounds that make marine organisms’ important source 
of biologically active substances using in therapeutics progress [11]. 
Chlorophyte alga Haematococcus pluvialis is the highest known source of 
astaxanthin (ASTA) in nature [12]. Where, ASTA content in H. pluvialis 
may exceed 4% of dry weight that is considered the highest content 
reported for any microorganism such as bacteria, fungi, and other 
microalgae [13]. Thus, H. pluvialis had a great interest for the commercial 
production of ASTA high value [14]. The basic and clinical research on 
ASTA health benefits have rapidly developed due to it has a preventive 
effect against oxidative stress-related diseases [15]. Moreover, ASTA 
has a considerable potential in the prohibition and handling of different 
diseases including cancer, asthma, metabolic syndrome, rheumatoid 
arthritis, gastrointestinal, hepatic, and neurodegenerative diseases [16].
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The aim of this study is to investigate the potential of H. pluvialis extract 




STZ was purchased from Sigma-Aldrich, India. All chemicals in this 
study were of analytical grade, products of Sigma, Merck and Aldrich. 
All kits were the products of Biosystems (Alcobendas, Madrid, Spain), 
Sigma Chemical Company (St. Louis, MO, USA), Biodiagnostic Company 
(Cairo, Egypt).
H. pluvialis cultivation
H. pluvialis (strain No. CCAP 34/7) was isolated by spreading 0.1 ml 
of water samples collected from Nile River phytoplankton using 
BG11 media for algal isolation [17] into petri dishes containing 
1.5% agar for solidification. Then, single colonies of algae were re-
cultivated in the specified liquid media as non-axenic batch cultures 
(50 ml) at 25±2°C and 24 hrs with continuous white fluorescent lamp 
intensity ≈2500 Lux. Cultivation was carried out on an open pond with 
a capacity of 70 L containing 55 L of growth media. After cultivation, 
the biomass was initially separated from the water by gravitational 
settling and then further concentrated by centrifugation [18], then 
dried at 40°C.
Preparation of ethanol extract
100 g of the algal powder was macerated in ethanol (80%) and shacked 
on shaker (Heidolph UNIMAX 2010) for 48 hrs at 150 rpm. The extract 
was filtered using a Buchner funnel and Whatman No. 4 filter paper, 
and the algal residue was re-extracted with the addition of fresh ethanol 
for another 2 times [19]. Combined filtrates were concentrated using 
Rotavapor (Heidolph-Germany) at a temperature of 40°C under vacuum 
to dryness. The evaporated extract so obtained was preserved at −20°C 
in a freeze and kept until further use.
Animals
About fifty male Wistar rats (180-200 g) raised in the Central Animal 
House, National Research Centre (NRC) were used. Animals were 
acclimatized to the laboratory conditions at room temperature before 
the experimentation. Animals were kept under standard conditions 
of a 12 hrs light/dark cycle with food and water in plastic cages with 
soft bedding. Before testing for blood glucose level or injection of STZ 
to induce diabetes, the rats were fasted overnight (at least 12 hrs) but 
had free access to water. The study was approved by the NRC Animal 
Ethical Committee Guidelines (approval no: 0111457) for the use and 
care of animals.
Diabetes induction and animals’ treatment
STZ was dissolved in 0.01 M citrate buffer immediately before use and 
induced by intraperitoneal injection of a single dose (45 mg/kg b.wt.) 
through the dorsal vein of the rats’ penis [20]. After STZ injection, rats 
had free access to food, water and were given 5% glucose solution to 
drink overnight to encounter hypoglycemic shock [21]. Fasted blood 
glucose levels were assessed 72 hrs after STZ injection as well as 
glycosuria to confirm the diabetic states. Rats were considered to be 
diabetic if glycosuria was present for three consecutive days [22]. Only 
rats with a fasting blood glucose level of ≥300 mg/dl and positive urine 
glucose were used in the experiment. The antidiabetic glibenclamide 
reference drug was orally administrated at a dose of 10 mg/kg b.wt. 
daily for 30 days [23].
Experimental study
About fifty rats were randomly divided into 5 groups of 10 in each 
group. Group 1: Normal control. Group 2: Normal rats treated with 
H. pluvialis ethanolic extract (150 mg/Kg b.wt.) [24]. Group 3: Diabetic 
rats. Group 4: Diabetic rats orally treated with H. pluvialis ethanol 
extract (150 mg/Kg b.wt.). Group 5: Diabetic rats orally administered 
antidiabetic glibenclamide reference drug (10 mg/kg b.wt.) daily for 
30 days.
Blood and tissue sample measurements
Rats were fasted overnight (12-14 hrs), anesthetized by diethyl ether 
and blood collected by puncture of the sublingual vein in clean and dry 
test tube, left 10 minutes to clot and centrifuged at 3000 rpm for serum. 
The separated serum was used for biochemical analysis of ADMA, vWf, 
15-LOX, 5-LOX, EGF, and LXA4.
Analytical methods
ADMA was determined in serum by ELIZA method according to 
Valtonen et al. [25] vWf was measured by a quantitative direct enzyme 
immunoassay according to Fischer et al. [26]. 15-LOX was determined 
in brain tissue by HPLC method according to Hoffman et al. [27]. 5-LOX 
was determined in brain tissue by colorimetric method according to 
Anthon and Barrett [28]. EGF was determined by Puchades et al. [29]. 
LXA4 invasion assay was performed using a method described 
previously by Elsinghorst [30].
Calculations:
% Change to control














After the sacrifice of rats, heart and kidney samples were dissected 
and extracted from animals. Heart and kidney tissues were fixed 
in 10% formalin for 1 week washed in running tap water for 24 hrs 
and dehydrated in ascending series of ethanol (50-90%), followed by 
absolute alcohol. The samples were cleared in xylene and immersed 
in a mixture of xylene and paraffin at 60°C. The tissues were then 
transferred to pure paraffin wax of the melting point 58°C and then 
mounted in blocks and left at 4°C. Serial sections of 5 microns thick 
were prepared and mounted on clean glass slides and left in the oven 
at 40°C to dryness. The slides were deparaffinized in xylene and then 
immersed in descending series of ethanol (90-50%). The ordinary 
hematoxylin and eosin (H and E) stain was used to stain the slides [31].
Statistical analysis
All the values were expressed as mean±standard deviation. Statistical 
differences between the means of various groups were evaluated by 
one-way analysis of variance using the Statistical Package for the Social 
Sciences (SPSS) program, version 11 followed by Co-state program to 
compare significance between groups. p-values of 0.05 or less were 
considered to be significant.
RESULTS
Effect of H. pluvialis extract on ADMA, vWf, 15-LOX, 5-LOX, EGF, and 
LXA4 levels in the different groups under investigation
The results in Table 1 showed the effect of H. pluvialis extract on 
ADMA, vWf, 15-LOX, 5-LOX, EGF, and LXA4 levels in different groups 
where insignificant change in their levels was recorded in normal rats 
treated with H. pluvialis extract. While increase in ADMA, vWf, 15-LOX, 
and 5-LOX levels was detected in diabetic rats (430.30, 77.54, 61.05, and 
81.09%, respectively), compared to normal control one. However, the 
EGF and LXA4 levels decreased in diabetic rats with percentages 44.17 
and 51.94%, respectively. On the other hand, treatment of diabetic rats 
with H. pluvialis improved ADMA, vWf, 15-LOX, 5-LOX, EGF, and LXA4 
levels with amelioration percentages 269.69, 54.77, 55.78, 72.68, 53.39, 
and 56.58%, respectively.
Histopathological examination of cardiac tissue
Microscopical examination of normal control heart revealed normal 
cardiac myocytes (Fig. 1). Meanwhile, the heart of diabetic rats showed 
vacuolation of the sarcoplasm of cardiac myocytes (Fig. 2a), congestion 
of myocardial blood vessels and focal necrosis of myocytes associated 
with inflammatory cells infiltration (Fig. 2b). Some examined 
sections from diabetic rats treated with H. pluvialis extract revealed 
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diabetic rat kidneys showed vacuolation of epithelial lining renal 
tubules and endothelial lining glomerular tuft as well as cystic dilatation 
of renal tubules (Figs. 6a and b). Moreover, examined sections from the 
diabetic group treated with H. pluvialis extract revealed vacuolation 
of epithelial lining renal tubules, endothelial lining glomerular tuft, 
congestion of glomerular tuft, and intertubular renal blood vessels 
(Figs. 7a and b). However, improved picture was observed in kidneys of 
diabetic rats treated with glibenclamide drug, as the examined sections 
revealed renal tubules with vacuolation of the epithelial lining as well 
as glomerular tufts with slight congestion (Figs. 8a and b).
DISCUSSION
The current results revealed elevation in ADMA in STZ-induced diabetic 
rats. The increased levels of ADMA have been also detected in diabetic 
patients [32]. High blood glucose level was demonstrated to enhance 
ADMA levels by decreased its metabolism [32]. Clinical investigations 
in patients also indicated that ADMA is directly related to blood glucose 
levels [32]. Recently, intense regulation of blood glucose levels may 
extend antiatherogenic influences by lowering the levels of ADMA in 
T2DM patients [33]. It was suggested that, the high concentrations 
of ADMA are distinctly connected with the cases of coronary artery 
disease [34], T2DM [35], type 1 diabetes [36], and chronic heart 
failure [37]. ADMA is related also to the progression of diabetic 
complication such as renal disease incidence in patients with diabetic 
nephropathy [3] and T2DM patients with retinopathy [38].
Further, type 2 diabetes in these results is associated with the significant 
elevation in vWf. High vWF levels have been correlated well with the 
high risk of development of type 2 diabetes [39]. Beside, vWF has been 
linked with the insulin resistance in diabetic or nondiabetic cases [40]. 
In this context, Frankel et al. [9] revealed that vWf is inconsistently 
related to CVD and this may be attributed to the link of vWF with type 2 
diabetes and insulin resistance. Dysfunction of endothelial cells is a 
systemic disease leading to atherosclerosis and CVD. Insulin resistance 
and diabetic status alleviated the connection between the high vWF 
and the increment in the CVD risk, pointing to vWF acts as a powerful 
moderator [9]. In addition, intense dysfunction of endothelial cells may 
be key atherogenic agents that responsible for the excess of 2-4 fold 
increase CVD risk observed in diabetes of type 2 [9].
The present results are also declared significant increase in 5 and 
15-LOX levels in diabetic rats. 5-LOX has been implicated in cancer, 
asthma, allergic rhinitis, osteoarthritis, and atherosclerosis, whereas 
15-LOX has been engaged in diabetic status, coagulation of blood, cancer 
Fig. 1: Heart of normal control rats showing normal cardiac 
myocytes (H and E ×400)
no histopathological changes with normal cardiac myocytes (Fig. 3). 
Moreover, marked improvement in the histopathological picture of 
diabetic rats heart-treated with glibenclamide drug (Fig. 4).
Histopathological examination of renal tissue
Microscopically, kidneys of rat from normal control group revealed the 
normal histological structure of renal parenchyma (Fig. 5). Meanwhile, 
Fig. 2: (a) Heart of diabetic rats showing congestion of myocardial 
blood vessel and vacuolation of the sarcoplasm of cardiac myocytes 
(H and E ×400), (b) Heart of diabetic rats showing congestion of 
myocardial blood vessel and focal necrosis of myocytes associated 
with inflammatory cells infiltration (H and E ×400)
a b
Table 1: Influence of H. pluvialis extract on ADMA, vWf, 15-LOX, 5-LOX, EGF, and LXA4 levels
Groups parameters Control Control+H. pluvialis Diabetes Diabetes+H. pluvialis Diabetes+drug
ADMA(µmol/l)
% Change










































































































Data are expressed as mean±SD of 10 rats in each group. Statistical analysis is performed using SPSS computer program (one way ANOVA) coupled with Co-state 
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as well as psoriasis [8]. Human reticulocyte; 15- LOX-1 is regarded as an 
important curative goal, especially for its function in different disorders 
such as atherogenic and diabetic conditions, Alzheimer’s disease, 
breast cancer, and stroke [8].
Concerning EGF, the present results demonstrated significant decrease 
in EGF in diabetic rats. Al-Ankily et al. [5] explained that STZ-induced 
diabetes affects the binding of 125-labeled EGF to hepatic membranes 
negatively. Scatchard statistics demonstrated that the reduction in the 
binding of EGF was related to a lower in the receptors number. These 
findings evidenced that, insulin deficiency is a principle cause for the 
reduction in hepatic EGF receptors [41]. Further, in diabetic condition, 
plasma, submandibular gland EGF levels as well as the granular 
convoluted tubules size, which manufacture EGF, were noticed to be 
significantly reduced [41].
Considering LXA4, the current results showed significant reduction 
in LXA4 level in STZ-induced type 2 diabetes. It was found that 
IL-4 cytokine promoted anti-inflammatory action by enhancing 
LXA4 formation. The general purpose of LXs are to inhibit the pro-
inflammatory prostaglandins, thromboxanes, isoprostanes and 
leukotrienes output, beside it, stimulates wound healing and dissolve 
inflammatory process hence, it repair tissues as well as the function 
of organs to normal. Hence, when the LXs synthesis is disturbed as 
in this findings, it could drive to a continual inflammation and hence 
tissue injury [24]. It was evidenced that the synthesis of LXs are 
Fig. 3: Heart of diabetic rats treated with Haematococcus pluvialis 
extract showing normal cardiac myocytes (H and E ×400)
Fig. 4: Heart of diabetic rats treated with glibenclamide drug 
showing no histopathological changes (H and E ×400)
Fig. 5: Kidney of normal control rats showing the normal 
histological structure of renal parenchyma (H and E ×400)
Fig. 6: (a) Kidney of diabetic rats showing vacuolation of 
epithelial lining renal tubules and endothelial lining glomerular 
tuft (H and E ×400), (b) Kidney of diabetic rat showing cystic 
dilatation of renal tubules (H and E ×400)
a b
Fig. 7: (a) Kidney of diabetic rats treated with H. pluvialis extract 
showing vacuolation of epithelial lining renal tubules and 
endothelial lining glomerular tuft (H and E ×400), (b) Kidney of 
diabetic rats treated with H. pluvialis extract showing congestion of 
glomerular tuft and intertubular renal blood vessels (H and E ×400)
a b
Fig. 8: (a) Kidney of diabetic rats treated with glibenclamide 
drug showing vacuolation of epithelial lining renal tubules 
(H and E ×400), (b) Kidney of diabetic rats treated with 
glibenclamide drug showing slight congestion of glomerular tuft 
(H and E ×400)
a b
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reduced on β cells of the pancreas and subjected to toxic agents such 
as IL-6, TNF-a, and migration inhibitory factor (MIF), which could lead 
to  β-cell  dysfunction  or  destruction  and  the  onset  of  diabetes  [42]. 
Thus, polyunsaturated fatty acids (PUFAs) and their anti-inflammatory 
molecules as LXs, suppress the output of different pro-inflammatory 
mediators included MIF and High-mobility group box 1 protein. Hence, 
they inhibit inflammation in various disorders as diabetes [42].
Accumulating evidence suggested that ASTA of H. pluvialis could 
do cardiac-preventative effects by ameliorating oxidative damage, 
inflammatory process, lipid, and glucose metabolism, hence improved 
architectures of cardiac and renal tissues as indicated in the present 
results. ASTA may also prevent diabetic nephropathy development by 
decrease renal oxidative stress and renal cell damage in db/db mice [43]. 
ASTA is commonly isomers mixture synthesized by H. pluvialis microalga 
and is used as a supplement in nutrition, as an antioxidant, it captures 
free radicals, prevents peroxidation of the lipid membrane bilayer [11]. 
Further, its property as antioxidant is 10-fold higher than other 
carotenoids,  as  lutein,  canthaxanthin,  and β-carotene  [11].  In parallel, 
a recent meta-analysis showed that ASTA supplementation can lower 
glucose levels [15]. ASTA was found to be more efficient than vitamin E, 
it preserves rat liver mitochondria against lipid peroxidation [44]. It can 
induce xenobiotic metabolizing enzymes in the lung and kidney [45].
CONCLUSION
It could be concluded that diabetic complications are associated with 
metabolic disorders in the different organs including cardiac and 
renal tissues. However, normalization in this metabolic dysfunction 
is documented on using H. pluvialis extract related to its ASTA 
content. Further, clinical investigations are needed to use H. pluvialis 
as a promising candidate nutraceutical for ameliorating diabetic 
complications.
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